This is the authors' abstract. We don't add key points for this paper.
Nanoscale coordination polymers (NCPs) containing a Pt(IV) cisplatin prodrug, disuccinatocisplatin, were formed by a surfactant-templated synthesis and were shown to have a prodrug loading of 8.2 wt% and a diameter of ∼133 nm by dynamic light scattering. These NCPs were stabilized by coating with a DOPC/cholesterol/DSPE-Peg2 K lipid layer; a release profile in phosphate buffered saline showed an initial drug release of ∼25% within the first hour and no more release observed up to 192 h. The NCP was rendered target-specific for sigma receptors by addition of a DSPE–Peg2 K–AA conjugate (AA = anisamide) in the lipid formulation. The AA-containing NCP showed a statistically significant decrease in IC50 (inhibitory concentration, 50%) compared to the non-targeted NCP. Enhanced uptake of the AA-containing NCP was further supported by confocal microscopy and competitive binding assays.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Huxford‐Phillips et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: